发明名称 Antibodies immunoreactive with heregulin-coupled HER3
摘要 Recombinant materials and methods for producing antibodies that specifically bind heregulin-coupled HER3, at a site distinct from the heregulin binding site, are described. These antibodies are particularly useful in treating cancer that expresses HER3.
申请公布号 US9321839(B2) 申请公布日期 2016.04.26
申请号 US201414475348 申请日期 2014.09.02
申请人 TRELLIS BIOSCIENCE, LLC 发明人 Keyt Bruce;Kauvar Lawrence M.;Collarini Ellen J.;Foord Orit;Sperinde Gizette;Fatholahi Marjan;Nguyen Hung
分类号 C07H21/04;A61K39/395;C07K16/28;C07K16/22;C07K16/30;C07K16/32;C07K16/40 主分类号 C07H21/04
代理机构 Morrison & Foerster LLP 代理人 Morrison & Foerster LLP
主权项 1. A recombinant expression system which comprises one or more nucleotide sequences that encode a monoclonal antibody or fragment thereof which binds to HER3 not complexed to heregulin, and binds to HER3:heregulin complex with greater affinity as compared to binding uncomplexed HER3, said one or more nucleotide sequences operably linked to control sequences for expression; wherein the encoded monoclonal antibody or fragment comprises a heavy chain that comprises CDR1:GYTFTDYVIS (SEQ ID NO:4), CDR2:IYPGSGRY (SEQ ID NO:5) and CDR3:TRSLQRLRYFDV (SEQ ID NO:6); and comprises a light chain that comprises CDR1:RASQSISDYLH (SEQ ID NO:10), CDR2:YGSQSIS (SEQ ID NO:11) and CDR3:QQSNSWPLT (SEQ ID NO:12).
地址 Menlo Park CA US